UCLA receives $13 million contract to expand COVID-19 testing

Share:

EmailFacebookLinkedInXWhatsAppShare
Grantee News
September 21, 2021

A new $13.3 million contract from the NIH's Rapid Acceleration of Diagnostics (RADx) initiative will enable the David Geffen School of Medicine at UCLA to expand its capacity to process COVID-19 tests.